Ionis Pharmaceuticals (IONS) Capital Expenditures Growth (3y) (2012 - 2026)
Ionis Pharmaceuticals (IONS) Capital Expenditures Growth (3y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,222.41 Bn | 67,222.13 Bn | - | - |
| 2 | Nanobiotix | 1,909.44 Bn | 1,909.38 Bn | - | - |
| 3 | Akari Therapeutics | 989.71 Bn | 989.71 Bn | - | - |
| 4 | BeOne Medicines | 471.12 Bn | 466.33 Bn | 1.35 Bn | -12.25% |
| 5 | Vertex Pharmaceuticals | 121.84 Bn | 114.59 Bn | 2.59 Bn | 46.88% |
| 6 | Regeneron Pharmaceuticals | 69.89 Bn | 61.14 Bn | 3.31 Bn | 8.97% |
| 7 | Belite Bio | 62.74 Bn | 62.74 Bn | - | - |
| 8 | Argenx Se | 55.83 Bn | 50.64 Bn | 1.41 Bn | - |
| 9 | Alnylam Pharmaceuticals | 37.34 Bn | 34.34 Bn | 959.66 Mn | 16.27% |
| 10 | Ionis Pharmaceuticals | 9.21 Bn | 7.29 Bn | 243.11 Mn | 27.61% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 27.61% |
| Dec 31, 2025 | -109.31% |
| Sep 30, 2025 | -1.66% |
| Jun 30, 2025 | 54.52% |
| Mar 31, 2025 | 66.91% |
| Dec 31, 2024 | 116.80% |
| Sep 30, 2024 | 39.68% |
| Jun 30, 2024 | 12.67% |
| Mar 31, 2024 | 36.36% |
| Dec 31, 2023 | -29.25% |
| Sep 30, 2023 | -43.38% |
| Jun 30, 2023 | -11.41% |
| Mar 31, 2023 | 126.27% |
| Dec 31, 2022 | -18.91% |
| Sep 30, 2022 | -29.62% |
| Jun 30, 2022 | -5.99% |
| Mar 31, 2022 | -5.73% |
| Dec 31, 2021 | 130.02% |
| Sep 30, 2021 | 37.82% |
| Jun 30, 2021 | -13.07% |